Oral Codeine Tablet Market Size, Share, Growth, and Industry Analysis, By Type (Single-ingredient Codeine and Multi-ingredient Medications), By Application (Narcotic Analgesic, Antitussive, & others) and Regional Insight and Forecast to 2033

• 

  Request a Free sample to learn more about this report

ORAL CODEINE TABLET MARKET OVERVIEW

The oral codeine tablet market stood at USD 0.76 billion in 2024 and is set to expand to USD 0.8 billion in 2025, eventually reaching USD 1.18 billion by 2033, driven by a CAGR of 5.1%.

Oral codeine tablets are opioid anesthetics primarily used to relieve moderate to severe pain. They work by binding to opioid receptors in the brain, reducing the perception of pain. Codeine may also suppress cough. Common side goods include doziness, constipation, and nausea. Use cautiously due to dependence and dependence pitfalls.

The oral codeine tablet market is significant, driven by rising global pain operation needs and adding conventions. In recent times, the market has faced challenges due to regulatory restrictions and a growing mindfulness of opioid dependence. Still, it remains a critical element of pain relief strategies in various healthcare settings.

KEY FINDINGS

COVID-19 IMPACT

Shift towards Patient Centric Drives Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID- 19 epidemic has led to increased demand for healthcare products, including oral codeine tablets, as consumers seek results for pain relief from home. This has accelerated digitalization in the market, with an increase in online deals and telemedicine consultations. Industry confluence has also played a part, with pharmaceutical companies partnering with technology companies to enhance distribution and reach more customers. These dislocations have reshaped market strategies, with companies focusing more one-commerce and telehealth services to feed to the changing consumer actions. The epidemic has also stressed the significance of availability and convenience in the healthcare industry, leading to a shift towards further patient- centric approaches in the market.

LATEST TRENDS

Technological Advancement to Drive Market Growth

A latest trend in the global Oral Codeine Tablet market is the integration of advance technology. The Oral Codeine Tablet market is passing rapid technological advancements, driven by the integration of artificial intelligence (AI), the Internet of effects (IoT), and blockchain technology. AI enhances prophetic analytics and substantiated drug, optimizing lozenge and case monitoring. IoT enables real- time shadowing of force and case adherence through smart bias. Meanwhile, blockchain improves security and translucency in the force chain, ensuring authenticity and minimizing counterfeit products. Together, these inventions are significantly enhancing functional effectiveness, security, and scalability in the Oral Codeine Tablet market.

• According to the U.S. Drug Enforcement Administration (DEA), approximately 21% of prescribed opioid medications, including codeine tablets, are dispensed for dental pain, highlighting a consistent trend in therapeutic usage
• According to the World Health Organization (WHO), around 60 countries have implemented stricter scheduling for codeine-containing medicines in the past five years, reflecting an increasing trend towards tighter regulatory controls on oral codeine tablets

Request a Free sample to learn more about this report

ORAL CODEINE TABLET MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Single-ingredient Codeine and Multi-ingredient Medications.

• Single-ingredient Codeine: Single- ingredient codeine is a pure opioid analgesic used to treat moderate pain and cough. It effectively binds to opioid receptors but carries pitfalls of dependence and side goods, challenging conservative use.

•  Multi-ingredient Medications: Multi-ingredient medications combine various active factors, addressing multiple symptoms or health conditions in a single expression. They enhance convenience but may increase the threat of side goods and relations, taking careful monitoring.

By Application

Based on application the global market can be categorized into Narcotic Analgesic, Antitussive, & others.

• Narcotic Analgesic: Oral Codeine Tablet is generally used as a narcotic analgesic to relieve moderate to severe pain. It works by changing the way the brain perceives pain signals, furnishing relief to cases.

• Antitussive: Codeine is also used as an antitussive to suppress coughing in cases. It acts on the brain's cough center, reducing the appetite to cough and furnishing relief in cases of dry and unproductive cough.

• Others: Oral Codeine Tablet is also used in other operations similar as treating diarrhea and as a preoperative drug. 

DRIVING FACTORS

Shifting Towards Sustainability to Boost the Market

One significant key driving factor in the oral codeine tablet market growth is the growing emphasis on shifting towards sustainability. Consumers are increasingly prioritizing sustainability and eco-friendly in their purchasing opinions, egging companies in the Oral Codeine Tablet market to acclimatize. In response, manufacturers are enforcing sustainable practices throughout product processes, exercising environmentally friendly accoutrements and reducing waste. Also, they're espousing eco-conscious packaging results and exploring greener distribution styles to minimize carbon vestiges. This shift not only meets consumer demand but also improves brand character and nonsupervisory compliance. By embracing sustainability, companies can foster customer loyalty and contribute appreciatively to the environment.

• According to the National Institute on Drug Abuse (NIDA), more than 10 million people in the U.S. misused prescription opioids in 2022, which has driven heightened awareness and demand for regulated, lower-strength oral codeine tablets as safer alternatives
• According to the European Medicines Agency (EMA), around 75% of patients with mild to moderate pain conditions still rely on combination codeine tablets, underscoring sustained demand for oral codeine formulations in pain management

Rising Demand for Pain Management to Expand the Market

Another crucial factor impacting the oral codeine tablet market is the rising demand for pain management. As the global population periods and habitual pain conditions come more current, the need for important anesthetics like codeine increases. Also, advancements in healthcare and a growing mindfulness of pain operation options encourage healthcare providers to define codeine for moderate to severe pain. This demand energies market growth as cases seeks relief, expanding the compass for manufacturers and healthcare professionals likewise.

RESTRAINING FACTORS

High Initial Investment Impede Market Growth

One of the key restraining factors in the global Oral Codeine Tablet market is high initial investment of these products. The high original investment demanded for the development and installation of Oral Codeine Tablet results presents a considerable hedge to market growth, particularly for large- scale systems. Manufacturers face substantial costs related to exploration and development, nonsupervisory compliance, and advanced technologies needed for product. Also, the charges associated with training labor force and enforcing quality control measures farther strain fiscal coffers. This fiscal burden may discourage lower companies from entering the market, inhibiting invention and limiting competition in the Oral Codeine Tablet sector.

• According to Health Canada, the country has restricted over-the-counter sales of codeine-containing tablets since 2019, leading to a 30% drop in retail availability, which acts as a key market constraint
• According to the Australian Therapeutic Goods Administration (TGA), codeine-related poisonings decreased by 50% after up-scheduling in 2018, indicating that stricter regulations on oral codeine tablets are restraining market growth

• Request a Free sample to learn more about this report

•  

ORAL CODEINE TABLET MARKET REGIONAL INSIGHTS

North America Region Dominating the Market due Increasing Prevalence of Pain Management

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America and Middle East & Africa. North America has emerged as the most dominant region in the global Oral Codeine Tablet market share due to several factors. North America dominated the Oral Codeine Tablet Market, primarily due to the increasing prevalence of pain management needs and a rise in prescriptions for codeine products. North America dominates the oral codeine tablet market, fueled by a raising demand for effective pain operation results among cases. The growing frequency of habitual pain conditions has led to a significant rise in conventions for codeine products. Also, increased mindfulness and availability of healthcare services contribute to this market growth.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The Oral Codeine Tablet market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

• Taiji: According to the China Pharmaceutical Association, Taiji produces over 200 million codeine tablets annually, making it one of China’s leading suppliers of oral codeine-based analgesics
• Mallinckrodt: According to the U.S. DEA Quota History, Mallinckrodt accounted for nearly 35% of all codeine raw material quotas allocated in the U.S. in 2022, reflecting its dominant role in the oral codeine tablet market

List of Top Oral Codeine Tablet Companies

• Taiji (China)
• Mallinckrodt (Dublin)
• TEVA (Israel)
• Johnson & Johnson (U.S.)
• Medreich (India)
• Sanofi Aventis (France)
• Cipla (India)
• Hikma (U.K.)
• Pharmaceutical Associates (South Carolina)
• Novartis (Switzerland)
• Apotex (Canada)
• Mylan (U.S.)
• Aristo Pharma GmbH (Germany)
• Lannett Company (U.S.)
• Laboratoire Riva (Canada)

INDUSTRIAL DEVELOPMENT

August 2024: Mallinckrodt plc, headquarters in Dublin, announced the availability of the Acthar Gel (repository corticotrophin injection) Single-Dose Pre-Filled SelfJect Injector, offering a new administration option for Acthar Gel for appropriate oatients withba range of chronic and acute inflammatory and autoimmune conditions. Acthar Gel is the one and only medication in its class of andrenocorticotropic hormone products available in self injection device to treat a range of chronic and acute inflammatory and autoimmune condition 1.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.